The importance of molecular diagnostics for infectious diseases in low-resource settings-Reference-Cited by-同舟云学术

The importance of molecular diagnostics for infectious diseases in low-resource settings

Published:2021-06-28 Issue:9 Volume:19 Page:547-548
ISSN:1740-1526
Container-title:Nature Reviews Microbiology
language:en
Short-container-title:Nat Rev Microbiol

Author:

Okeke Iruka N.^ORCID,Ihekweazu Chikwe

Publisher

Springer Science and Business Media LLC

Subject

General Immunology and Microbiology,Microbiology,Infectious Diseases

Link

https://www.nature.com/articles/s41579-021-00598-5.pdf

Reference10 articles.

1. Ombelet, S. et al. Clinical bacteriology in low-resource settings: today’s solutions. Lancet Infect. Dis. 18, e248–e258 (2018).

2. Okeke, I. N. et al. Leapfrogging laboratories: the promise and pitfalls of high-tech solutions for antimicrobial resistance surveillance in low-income settings. BMJ Glob. Health 5, e003622 (2020).

3. Naidoo, D. & Ihekweazu, C. Nigeria’s efforts to strengthen laboratory diagnostics - why access to reliable and affordable diagnostics is key to building resilient laboratory systems. Afr. J. Lab. Med. 9, 1019 (2020).

4. Saha, S. & Pai, M. Can COVID-19 innovations and systems help low- and middle-income countries to re-imagine healthcare delivery? Med (N.Y.) 2, 369–373 (2021).

5. Okomo, U. et al. Investigation of sequential outbreaks of Burkholderia cepacia and multidrug-resistant extended spectrum β-lactamase producing Klebsiella species in a West African tertiary hospital neonatal unit: a retrospective genomic analysis. Lancet Microbe 1, e119–e129 (2020).

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent progress in molecular diagnostics: The synergy of rolling circle amplification and CRISPR/Cas systems (2018–2024) – A concise review;TrAC Trends in Analytical Chemistry;2024-11

2. Viral sequencing to inform the global elimination of dog-mediated rabies - a systematic review;One Health & Implementation Research;2024-05-31

3. FDA’s proposed rule and its regulatory impact on emerging and reemerging neglected tropical diseases in the United States;PLOS Neglected Tropical Diseases;2024-05-09

4. Sample-to-result molecular diagnostic platforms and their suitability for infectious disease testing in low- and middle-income countries;Expert Review of Molecular Diagnostics;2024-05-03

5. Unveiling the menace: a thorough review of potential pandemic fungal disease;Frontiers in Fungal Biology;2024-04-22